FOCUS laboratories have introduced 5 new biomarkers that allow to assess important functions of the defense system against bacterial and viral infections.

The parameters include assays for neutrophil oxidative burst, c<LINK...

Monoclonal antibodies (mabs) are already an important element in modern pharmacotherapy and many promising antibody candidates with more potency and novel modes of-action are presently being developed. The problems that are associated with clinical trials of biologicals - and specifically monoclonal antibodies - have been sadly demonstrated by the...